---
title: Collaborative virtual reality improves walking
nct_id: NCT07523425
phase: NA
status: RECRUITING
sponsor: Superior University
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07523425"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07523425"
last_fetched: "2026-05-10T14:02:33.616Z"
source: "Parkinson's Pathways (curated)"
---
# Collaborative virtual reality improves walking

**Goal (in five words):** Collaborative virtual reality improves walking

**Official Title:** COMPARATIVE EFFECTIVENESS of COLLABORATIVE VIRTUAL ENVIRONMENT and NON-IMMERSIVE VIRTUAL REALITY in the REHABILITATION of PATIENTS With PARKINSON'S DISEASE

**Trial ID:** [NCT07523425](https://clinicaltrials.gov/study/NCT07523425)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Superior University
- **Target Enrollment:** 60 participants
- **Start Date:** 2025-05-27
- **Completion Date:** 2026-09-27
- **Conditions:** Parkinson Desease
- **Interventions:** Collaborative Virtual Environment, Non-Immersive Virtual Reality (NIVR)
- **Intervention Types:** OTHER

## Summary For Families

Goal: to see whether a collaborative virtual environment where people work together in the same virtual space improves balance, gait, and everyday motor function more than standard non-immersive, screen-based virtual reality. Approach: participants do guided, task-based exercises using sensors or a screen, the collaborative setup adds social interaction and real-time visual and auditory feedback to boost motor learning, while the non-immersive option gives individual practice; both are rehab tools meant to complement, not replace, stable Parkinson's medications. Eligibility: adults 45 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages I to III, on stable conventional treatment, with no severe cognitive impairment (MMSE ≥ 24) and able to tolerate virtual sessions, excluding people with severe sensory problems, epilepsy, or other conditions that block participation.

## Eligibility

- **Minimum age:** 45 Years
- **Maximum age:** 80 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Male and Female
* Age: 45 years-80 Years
* Diagnosed patients of idiopathic Parkinson Disease with minor to moderate severity according to the Hoehn \& Yahr stages I-III.
* On conventional and stable medical treatment at present
* No severe cognitive impairments (MMSE ≥ 24).
* Ability to participate in virtual rehabilitation sessions
* Willingness to participate and provide informed consent

Exclusion Criteria:

* Severe visual, auditory, or motor impairments unrelated to Parkinson's.
* Fear of virtual environment.
* Comorbidities that hinder participation in the treatment (e.g., advanced dementia).
* Severe musculoskeletal conditions limiting movement
* History of epilepsy or conditions contraindicating virtual reality exposure
* Participation in another interventional study within the last 3 months
```

## Locations (1)

- Punjab Institute of Neurosciences Lahore, Lahore, Punjab Province, Pakistan _(31.5580, 74.3507)_

## Central Contacts

- Hafiz Muddassir Riaz — (CONTACT) — +923456627409 — muddassir.riaz@gmail.com

---

*Canonical: https://parkinsonspathways.com/trial/NCT07523425*  
*HTML version: https://parkinsonspathways.com/trial/NCT07523425*  
*Source data: https://clinicaltrials.gov/study/NCT07523425*